ADVANCED HEPATOCELLULAR CARCINOMA
Clinical trials for ADVANCED HEPATOCELLULAR CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ADVANCED HEPATOCELLULAR CARCINOMA trials appear
Sign up with your email to follow new studies for ADVANCED HEPATOCELLULAR CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental cell therapy tested in advanced liver cancer patients
Disease control OngoingThis is an early Phase 1 study to check the safety and find the right dose of an experimental cell therapy called CT0180 for people with advanced liver cancer. The study will enroll 21 patients who have already tried other treatments. Researchers will give patients one or more in…
Matched conditions: ADVANCED HEPATOCELLULAR CARCINOMA
Phase: PHASE1 • Sponsor: Zhejiang University • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Personalized immune cells take aim at tough liver cancers
Disease control TerminatedThis early-stage study is testing a new treatment for advanced liver cancer that has come back or stopped responding to standard therapies. Doctors take a patient's own immune cells, modify them in a lab to better recognize and attack cancer cells, and then infuse them back into …
Matched conditions: ADVANCED HEPATOCELLULAR CARCINOMA
Phase: PHASE1 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
Singapore hospital tests novel RNA therapy in fight against advanced liver cancer
Disease control OngoingThis early-stage study is testing the safety and best dose of a new three-drug combination for people with advanced liver cancer (hepatocellular carcinoma) who haven't had other drug treatments. The combination adds a new experimental RNA drug (MTL-CEBPA) to two existing cancer d…
Matched conditions: ADVANCED HEPATOCELLULAR CARCINOMA
Phase: PHASE1 • Sponsor: National University Hospital, Singapore • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New Two-Drug combo tested for Tough-to-Treat liver cancer
Disease control OngoingThis study is testing a combination of two immunotherapy drugs, durvalumab and tremelimumab, as a first treatment for people with advanced liver cancer that cannot be removed by surgery. It aims to see how safe the treatment is and how well it controls the cancer. The trial is fo…
Matched conditions: ADVANCED HEPATOCELLULAR CARCINOMA
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New combo therapy trial offers hope for HIV patients with advanced cancers
Disease control OngoingThis is a small, early-stage safety study testing a combination of two cancer drugs, nivolumab and cabozantinib, in people living with HIV who have advanced solid tumors. The main goal is to see if the two-drug combination is safe and tolerable for this specific patient group. Re…
Matched conditions: ADVANCED HEPATOCELLULAR CARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC